Empagliflozin Induced Fanconi Syndrome in a Patient with COVID-19

Authors

Nicole Fernandez, HCA HealthcareFollow
Gilad Guez, HCA HealthcareFollow
Edgar Escasinas

Files

Division

Capital

Hospital

LewisGale Medical Center

Specialty

Internal Medicine

Document Type

Poster

Publication Date

2023

Keywords

Fanconi Syndrome, COVID-19, Drug-Related Side Effects and Adverse Reactions

Disciplines

Female Urogenital Diseases and Pregnancy Complications | Internal Medicine | Medicine and Health Sciences | Virus Diseases

Original Publisher

HCA Healthcare Graduate Medical Education

Recommended Citation

Fernandez, Nicole; Guez, Gilad; and Escasinas, Edgar, "Empagliflozin Induced Fanconi Syndrome in a Patient with COVID-19" (2023). Capital Division GME Research Day 2023. 7.
https://scholarlycommons.hcahealthcare.com/capital2023/7